Literature DB >> 25400787

Systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder: a case report and review of literature.

Xia Tan1, Xianling Liu2, Chunhong Hu2, Fuyou Liu1, Fang Wu2.   

Abstract

Systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder (EBV + LPD) has predominantly been observed among pediatric patients as a life-threatening condition. The present study presents a rare case of EBV + LPD in an adult with good outcome. This patient's history is more than 2 years and her condition was stable. She received 6 cycles of chemotherapy cyclophosphamide/doxorubicin/vincristine/prednisolone (CHOP). The evaluation was complete remission. The low levels of EBV-DNA in the peripheral blood may have potential benefit factor for the sensitivity to the chemotherapy and good outcome.

Entities:  

Keywords:  Epstein-Barr virus; T/natural killer-cell; lymphoproliferative disorder

Mesh：

Substances：

Year:  2014        PMID： 25400787      PMCID： PMC4230129     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN： 1936-2625


  11 in total

1.  Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis.

Authors:  Ayako Arai; Ken-Ichi Imadome; Yuko Watanabe; Mayumi Yoshimori; Takatoshi Koyama; Takeharu Kawaguchi; Chiaki Nakaseko; Shigeyoshi Fujiwara; Osamu Miura
Journal:  Int J Hematol       Date:  2011-04-14       Impact factor: 2.490

2.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

3.  T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.

Authors:  Yasushi Isobe; Nanae Aritaka; Yasuhiro Setoguchi; Yoshinori Ito; Hiroshi Kimura; Yasuharu Hamano; Koichi Sugimoto; Norio Komatsu
Journal:  J Clin Pathol       Date:  2012-01-13       Impact factor: 3.411

4.  Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

Authors:  Jeffrey I Cohen; Elaine S Jaffe; Janet K Dale; Stefania Pittaluga; Helen E Heslop; Cliona M Rooney; Stephen Gottschalk; Catherine M Bollard; V Koneti Rao; Adriana Marques; Peter D Burbelo; Siu-Ping Turk; Rachael Fulton; Alan S Wayne; Richard F Little; Mitchell S Cairo; Nader K El-Mallawany; Daniel Fowler; Claude Sportes; Michael R Bishop; Wyndham Wilson; Stephen E Straus
Journal:  Blood       Date:  2011-03-31       Impact factor: 22.113

5.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Authors:  Hiroshi Kimura; Yoshinori Ito; Shinji Kawabe; Kensei Gotoh; Yoshiyuki Takahashi; Seiji Kojima; Tomoki Naoe; Shinichi Esaki; Atsushi Kikuta; Akihisa Sawada; Keisei Kawa; Koichi Ohshima; Shigeo Nakamura
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

Review 6.  Epstein-Barr virus: the impact of scientific advances on clinical practice.

Authors:  Hilary Williams; Dorothy H Crawford
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

Review 7.  The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.

Authors:  Elaine S Jaffe
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 8.  Epstein-Barr virus-associated lymphoproliferative disorders.

Authors:  Sherif A Rezk; Lawrence M Weiss
Journal:  Hum Pathol       Date:  2007-09       Impact factor: 3.466

9.  An adult case of systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder with good outcome.

Authors:  Xiuming Zhang; Zhaoming Wang; Lijun Wang; Hongtian Yao
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

Review 10.  Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

Authors:  Koichi Ohshima; Hiroshi Kimura; Tadashi Yoshino; Chul Woo Kim; Young H Ko; Seung-Suk Lee; Suat-Cheng Peh; John K C Chan
Journal:  Pathol Int       Date:  2008-04       Impact factor: 2.534
View more
  1 in total

1.  Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report.

Authors:  Masayo Yamamoto; Motohiro Shindo; Chihiro Sumi; Sho Igarashi; Takeshi Saito; Nodoka Tsukada; Yasumichi Toki; Mayumi Hatayama; Junki Inamura; Kazuya Sato; Yusuke Mizukami; Yoshihiro Torimoto; Toshikatsu Okumura
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.